Fibrinolysis: Biochemistry, Clinical Aspects, and Therapeutic Potential

Hau Kwaan; Ton Lisman; Robert L. Medcalf

doi:10.1055/s-0036-1598000

Fibrinolysis: Biochemistry, Clinical Aspects, and Therapeutic Potential

Hau Kwaan^*, Ton Lisman, Robert L. Medcalf

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Original language	English (US)
Article number	02414
Pages (from-to)	113-114
Number of pages	2
Journal	Seminars in thrombosis and hemostasis
Volume	43
Issue number	2
DOIs	https://doi.org/10.1055/s-0036-1598000
State	Published - Mar 1 2017

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Hematology

Access to Document

10.1055/s-0036-1598000

Cite this

@article{e6c8e4bfcdb841119395cbd8c59c3c45,

title = "Fibrinolysis: Biochemistry, Clinical Aspects, and Therapeutic Potential",

author = "Hau Kwaan and Ton Lisman and Medcalf, {Robert L.}",

year = "2017",

month = mar,

day = "1",

doi = "10.1055/s-0036-1598000",

language = "English (US)",

volume = "43",

pages = "113--114",

journal = "Seminars in thrombosis and hemostasis",

issn = "0094-6176",

publisher = "Thieme Medical Publishers",

number = "2",

}

TY - JOUR

T1 - Fibrinolysis

T2 - Biochemistry, Clinical Aspects, and Therapeutic Potential

AU - Kwaan, Hau

AU - Lisman, Ton

AU - Medcalf, Robert L.

PY - 2017/3/1

Y1 - 2017/3/1

UR - http://www.scopus.com/inward/record.url?scp=85014492498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014492498&partnerID=8YFLogxK

U2 - 10.1055/s-0036-1598000

DO - 10.1055/s-0036-1598000

M3 - Article

C2 - 28253534

AN - SCOPUS:85014492498

SN - 0094-6176

VL - 43

SP - 113

EP - 114

JO - Seminars in thrombosis and hemostasis

JF - Seminars in thrombosis and hemostasis

IS - 2

M1 - 02414

ER -

Fibrinolysis: Biochemistry, Clinical Aspects, and Therapeutic Potential

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this